Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HALO: Heparin in Septic Shock
NCT03378466Phase 2Terminated
- Sponsor
- University of Manitoba
- Start
- Mar 2018
- Primary completion
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of heparin in septic shock, sponsored by University of Manitoba. Started Mar 2018; status: terminated.
02
Drugs
heparin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03378466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03378466.